A
Adviye Ergul
Researcher at Medical University of South Carolina
Publications - 213
Citations - 8882
Adviye Ergul is an academic researcher from Medical University of South Carolina. The author has contributed to research in topics: Stroke & Diabetes mellitus. The author has an hindex of 48, co-authored 188 publications receiving 7678 citations. Previous affiliations of Adviye Ergul include Charlie Norwood VA Medical Center & United States Department of Veterans Affairs.
Papers
More filters
Journal ArticleDOI
Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice
TL;DR: New strategies with classic as well as new antioxidants should be implemented in the treatment of diabetes, as it is becoming clear that rather than merely scavenging reactive radicals, a more comprehensive approach aimed at preventing the generation of these reactive species may prove more beneficial.
Journal ArticleDOI
Targets for Vascular Protection After Acute Ischemic Stroke
TL;DR: The purpose of this review is to identify the pathophysiologic processes involved in vascular damage after ischemia, which may lead to strategies to provide vascular protection in ischemic stroke patients.
Journal ArticleDOI
Angiogenesis A Harmonized Target for Recovery After Stroke
TL;DR: The evidence that angiogenesis is a target for recovery after an ischemic stroke is evaluated and it is unclear whether the angiogenic response leads to the development of functional new blood vessels that improve brain function after stroke.
Journal ArticleDOI
Minocycline to Improve Neurologic Outcome in Stroke (MINOS): A Dose-Finding Study
Susan C. Fagan,Susan C. Fagan,Jennifer L. Waller,Fenwick T. Nichols,David J. Edwards,L. Creed Pettigrew,Wayne M. Clark,Christiana E. Hall,Jeffrey A. Switzer,Adviye Ergul,Adviye Ergul,David C. Hess,David C. Hess +12 more
TL;DR: An early phase trial of intravenous minocycline in acute ischemic stroke found the drug is safe and well tolerated up to doses of 10 mg/kg intravenously alone and in combination with tissue plasminogen activator.
Journal ArticleDOI
Within the Brain: The Renin Angiotensin System.
Ladonya Jackson,Wael Eldahshan,Susan C. Fagan,Susan C. Fagan,Adviye Ergul,Adviye Ergul,Adviye Ergul +6 more
TL;DR: In this review, the preclinical and clinical evidence for the impact of RAS modulators on cognitive impairment of multiple etiologies will be discussed and the expression and function of different receptor subtypes within the RAS, on different cell types within the brain are presented.